Building upon the success of last year's Stories of Women-Led Innovation Event, this forum continued highlighting the achievements and challenges faced by our women innovators and demystifying the innovation pathway through presentations and panel discussions. Sessions covered intellectual property protection, building inclusive teams and addressing bias in the context of academic innovation.
Attendees were excited to hear from our keynote speaker, Gitanjali Rao, aspiring scientist, inventor and author!
Lily Elizabeth Feldman has been a member of the CU Innovations team since 2021, when she started as a Venture Fellow during her PhD training. Since completing her degree, she has joined the team full-time as the Faculty Innovations Program Manager. In this role, Lily acts as a conduit to help researchers and clinicians across the Anschutz Medical Campus connect with the CU Innovations team. She integrates science, business, and communication to promote interdisciplinary partnerships that accelerate progress toward patient impact.
Lily has a Bachelor of Science in Biochemistry with minors in Chinese Language and Psychology from the University of New Mexico, and a PhD in Pharmacology and Molecular Medicine with a specialty in cancer therapeutics from the University of Colorado Anschutz Medical Campus.
Lily Elizabeth Feldman has been a member of the CU Innovations team since 2021, when she started as a Venture Fellow during her PhD training. Since completing her degree, she has joined the team full-time as the Faculty Innovations Program Manager. In this role, Lily acts as a conduit to help researchers and clinicians across the Anschutz Medical Campus connect with the CU Innovations team. She integrates science, business, and communication to promote interdisciplinary partnerships that accelerate progress toward patient impact.
Lily has a Bachelor of Science in Biochemistry with minors in Chinese Language and Psychology from the University of New Mexico, and a PhD in Pharmacology and Molecular Medicine with a specialty in cancer therapeutics from the University of Colorado Anschutz Medical Campus.
Lily Elizabeth Feldman has been a member of the CU Innovations team since 2021, when she started as a Venture Fellow during her PhD training. Since completing her degree, she has joined the team full-time as the Faculty Innovations Program Manager. In this role, Lily acts as a conduit to help researchers and clinicians across the Anschutz Medical Campus connect with the CU Innovations team. She integrates science, business, and communication to promote interdisciplinary partnerships that accelerate progress toward patient impact.
Lily has a Bachelor of Science in Biochemistry with minors in Chinese Language and Psychology from the University of New Mexico, and a PhD in Pharmacology and Molecular Medicine with a specialty in cancer therapeutics from the University of Colorado Anschutz Medical Campus.
Lily Elizabeth Feldman has been a member of the CU Innovations team since 2021, when she started as a Venture Fellow during her PhD training. Since completing her degree, she has joined the team full-time as the Faculty Innovations Program Manager. In this role, Lily acts as a conduit to help researchers and clinicians across the Anschutz Medical Campus connect with the CU Innovations team. She integrates science, business, and communication to promote interdisciplinary partnerships that accelerate progress toward patient impact.
Lily has a Bachelor of Science in Biochemistry with minors in Chinese Language and Psychology from the University of New Mexico, and a PhD in Pharmacology and Molecular Medicine with a specialty in cancer therapeutics from the University of Colorado Anschutz Medical Campus.
Lily Elizabeth Feldman has been a member of the CU Innovations team since 2021, when she started as a Venture Fellow during her PhD training. Since completing her degree, she has joined the team full-time as the Faculty Innovations Program Manager. In this role, Lily acts as a conduit to help researchers and clinicians across the Anschutz Medical Campus connect with the CU Innovations team. She integrates science, business, and communication to promote interdisciplinary partnerships that accelerate progress toward patient impact.
Lily has a Bachelor of Science in Biochemistry with minors in Chinese Language and Psychology from the University of New Mexico, and a PhD in Pharmacology and Molecular Medicine with a specialty in cancer therapeutics from the University of Colorado Anschutz Medical Campus.
Lily Elizabeth Feldman has been a member of the CU Innovations team since 2021, when she started as a Venture Fellow during her PhD training. Since completing her degree, she has joined the team full-time as the Faculty Innovations Program Manager. In this role, Lily acts as a conduit to help researchers and clinicians across the Anschutz Medical Campus connect with the CU Innovations team. She integrates science, business, and communication to promote interdisciplinary partnerships that accelerate progress toward patient impact.
Lily has a Bachelor of Science in Biochemistry with minors in Chinese Language and Psychology from the University of New Mexico, and a PhD in Pharmacology and Molecular Medicine with a specialty in cancer therapeutics from the University of Colorado Anschutz Medical Campus.
Lily Elizabeth Feldman has been a member of the CU Innovations team since 2021, when she started as a Venture Fellow during her PhD training. Since completing her degree, she has joined the team full-time as the Faculty Innovations Program Manager. In this role, Lily acts as a conduit to help researchers and clinicians across the Anschutz Medical Campus connect with the CU Innovations team. She integrates science, business, and communication to promote interdisciplinary partnerships that accelerate progress toward patient impact.
Lily has a Bachelor of Science in Biochemistry with minors in Chinese Language and Psychology from the University of New Mexico, and a PhD in Pharmacology and Molecular Medicine with a specialty in cancer therapeutics from the University of Colorado Anschutz Medical Campus.
This event aimed to educate and inspire entrepreneurs at all stages. Featuring panels on company formation, funding biomedical discoveries and creating strategic alliances, each session included interactive elements and the chance to network with potential partners from the Anschutz campus and beyond.
Attendees got to know Jodie Morrison, CEO of Q32 Bio, and Kimberly Muller, Executive Director of CU Innovations, through their Fireside Chat Keynote.
Lily Elizabeth Feldman has been a member of the CU Innovations team since 2021, when she started as a Venture Fellow during her PhD training. Since completing her degree, she has joined the team full-time as the Faculty Innovations Program Manager. In this role, Lily acts as a conduit to help researchers and clinicians across the Anschutz Medical Campus connect with the CU Innovations team. She integrates science, business, and communication to promote interdisciplinary partnerships that accelerate progress toward patient impact.
Lily has a Bachelor of Science in Biochemistry with minors in Chinese Language and Psychology from the University of New Mexico, and a PhD in Pharmacology and Molecular Medicine with a specialty in cancer therapeutics from the University of Colorado Anschutz Medical Campus.
Lily Elizabeth Feldman has been a member of the CU Innovations team since 2021, when she started as a Venture Fellow during her PhD training. Since completing her degree, she has joined the team full-time as the Faculty Innovations Program Manager. In this role, Lily acts as a conduit to help researchers and clinicians across the Anschutz Medical Campus connect with the CU Innovations team. She integrates science, business, and communication to promote interdisciplinary partnerships that accelerate progress toward patient impact.
Lily has a Bachelor of Science in Biochemistry with minors in Chinese Language and Psychology from the University of New Mexico, and a PhD in Pharmacology and Molecular Medicine with a specialty in cancer therapeutics from the University of Colorado Anschutz Medical Campus.
Lily Elizabeth Feldman has been a member of the CU Innovations team since 2021, when she started as a Venture Fellow during her PhD training. Since completing her degree, she has joined the team full-time as the Faculty Innovations Program Manager. In this role, Lily acts as a conduit to help researchers and clinicians across the Anschutz Medical Campus connect with the CU Innovations team. She integrates science, business, and communication to promote interdisciplinary partnerships that accelerate progress toward patient impact.
Lily has a Bachelor of Science in Biochemistry with minors in Chinese Language and Psychology from the University of New Mexico, and a PhD in Pharmacology and Molecular Medicine with a specialty in cancer therapeutics from the University of Colorado Anschutz Medical Campus.
Lily Elizabeth Feldman has been a member of the CU Innovations team since 2021, when she started as a Venture Fellow during her PhD training. Since completing her degree, she has joined the team full-time as the Faculty Innovations Program Manager. In this role, Lily acts as a conduit to help researchers and clinicians across the Anschutz Medical Campus connect with the CU Innovations team. She integrates science, business, and communication to promote interdisciplinary partnerships that accelerate progress toward patient impact.
Lily has a Bachelor of Science in Biochemistry with minors in Chinese Language and Psychology from the University of New Mexico, and a PhD in Pharmacology and Molecular Medicine with a specialty in cancer therapeutics from the University of Colorado Anschutz Medical Campus.
Lily Elizabeth Feldman has been a member of the CU Innovations team since 2021, when she started as a Venture Fellow during her PhD training. Since completing her degree, she has joined the team full-time as the Faculty Innovations Program Manager. In this role, Lily acts as a conduit to help researchers and clinicians across the Anschutz Medical Campus connect with the CU Innovations team. She integrates science, business, and communication to promote interdisciplinary partnerships that accelerate progress toward patient impact.
Lily has a Bachelor of Science in Biochemistry with minors in Chinese Language and Psychology from the University of New Mexico, and a PhD in Pharmacology and Molecular Medicine with a specialty in cancer therapeutics from the University of Colorado Anschutz Medical Campus.
Lily Elizabeth Feldman has been a member of the CU Innovations team since 2021, when she started as a Venture Fellow during her PhD training. Since completing her degree, she has joined the team full-time as the Faculty Innovations Program Manager. In this role, Lily acts as a conduit to help researchers and clinicians across the Anschutz Medical Campus connect with the CU Innovations team. She integrates science, business, and communication to promote interdisciplinary partnerships that accelerate progress toward patient impact.
Lily has a Bachelor of Science in Biochemistry with minors in Chinese Language and Psychology from the University of New Mexico, and a PhD in Pharmacology and Molecular Medicine with a specialty in cancer therapeutics from the University of Colorado Anschutz Medical Campus.
Congratulations to the judge vote winner, NowVitals pitched by Robin Deterding, MD, and the audience vote winner, Vināśa Oncology pitched by Sujatha Venkataraman, PhD!
Lily Elizabeth Feldman has been a member of the CU Innovations team since 2021, when she started as a Venture Fellow during her PhD training. Since completing her degree, she has joined the team full-time as the Faculty Innovations Program Manager. In this role, Lily acts as a conduit to help researchers and clinicians across the Anschutz Medical Campus connect with the CU Innovations team. She integrates science, business, and communication to promote interdisciplinary partnerships that accelerate progress toward patient impact.
Lily has a Bachelor of Science in Biochemistry with minors in Chinese Language and Psychology from the University of New Mexico, and a PhD in Pharmacology and Molecular Medicine with a specialty in cancer therapeutics from the University of Colorado Anschutz Medical Campus.
Lily Elizabeth Feldman has been a member of the CU Innovations team since 2021, when she started as a Venture Fellow during her PhD training. Since completing her degree, she has joined the team full-time as the Faculty Innovations Program Manager. In this role, Lily acts as a conduit to help researchers and clinicians across the Anschutz Medical Campus connect with the CU Innovations team. She integrates science, business, and communication to promote interdisciplinary partnerships that accelerate progress toward patient impact.
Lily has a Bachelor of Science in Biochemistry with minors in Chinese Language and Psychology from the University of New Mexico, and a PhD in Pharmacology and Molecular Medicine with a specialty in cancer therapeutics from the University of Colorado Anschutz Medical Campus.
With sessions featuring scientific talks, career panels, and a 2-hour networking lunch, RMBTS offered a prime platform to highlight scientific advancements and career opportunities, and foster collaboration within Colorado's scientific community.
Lily Elizabeth Feldman has been a member of the CU Innovations team since 2021, when she started as a Venture Fellow during her PhD training. Since completing her degree, she has joined the team full-time as the Faculty Innovations Program Manager. In this role, Lily acts as a conduit to help researchers and clinicians across the Anschutz Medical Campus connect with the CU Innovations team. She integrates science, business, and communication to promote interdisciplinary partnerships that accelerate progress toward patient impact.
Lily has a Bachelor of Science in Biochemistry with minors in Chinese Language and Psychology from the University of New Mexico, and a PhD in Pharmacology and Molecular Medicine with a specialty in cancer therapeutics from the University of Colorado Anschutz Medical Campus.
Lily Elizabeth Feldman has been a member of the CU Innovations team since 2021, when she started as a Venture Fellow during her PhD training. Since completing her degree, she has joined the team full-time as the Faculty Innovations Program Manager. In this role, Lily acts as a conduit to help researchers and clinicians across the Anschutz Medical Campus connect with the CU Innovations team. She integrates science, business, and communication to promote interdisciplinary partnerships that accelerate progress toward patient impact.
Lily has a Bachelor of Science in Biochemistry with minors in Chinese Language and Psychology from the University of New Mexico, and a PhD in Pharmacology and Molecular Medicine with a specialty in cancer therapeutics from the University of Colorado Anschutz Medical Campus.
Lily Elizabeth Feldman has been a member of the CU Innovations team since 2021, when she started as a Venture Fellow during her PhD training. Since completing her degree, she has joined the team full-time as the Faculty Innovations Program Manager. In this role, Lily acts as a conduit to help researchers and clinicians across the Anschutz Medical Campus connect with the CU Innovations team. She integrates science, business, and communication to promote interdisciplinary partnerships that accelerate progress toward patient impact.
Lily has a Bachelor of Science in Biochemistry with minors in Chinese Language and Psychology from the University of New Mexico, and a PhD in Pharmacology and Molecular Medicine with a specialty in cancer therapeutics from the University of Colorado Anschutz Medical Campus.
Lily Elizabeth Feldman has been a member of the CU Innovations team since 2021, when she started as a Venture Fellow during her PhD training. Since completing her degree, she has joined the team full-time as the Faculty Innovations Program Manager. In this role, Lily acts as a conduit to help researchers and clinicians across the Anschutz Medical Campus connect with the CU Innovations team. She integrates science, business, and communication to promote interdisciplinary partnerships that accelerate progress toward patient impact.
Lily has a Bachelor of Science in Biochemistry with minors in Chinese Language and Psychology from the University of New Mexico, and a PhD in Pharmacology and Molecular Medicine with a specialty in cancer therapeutics from the University of Colorado Anschutz Medical Campus.
PLATINUM SPONSORS:
SPONSORS: